Hot off the press !! Again !!

Porsolt is thrilled to already have our third paper published for this year: “Anti-CTLA-4 and anti-PD-1 immunotherapies repress tumor progression in preclinical breast and colon model with independent regulatory T…

Continue Reading Hot off the press !! Again !!

SAFETY REGULATORY PACKAGE

SAFETY REGULATORY PACKAGE Porsolt’s broad expertise and years of preclinical pharmacology experience makes us the ideal partner to conduct your GLP Safety Pharmacology experiments. Porsolt offers safety studies in both…

Continue Reading SAFETY REGULATORY PACKAGE

PAIN

PAIN Porsolt offers models of acute and chronic pain and inflammation matching the needs of the industry and maintaining a recognized expertise, which addresses pain therapeutic endpoints and pain associated…

Continue Reading PAIN